Aevis Victoria SA (AEVS):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Aevis Victoria SA (AEVS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10164
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Aevis Victoria SA (Aevis Victoria), a subsidiary of Medical Research, Services & Investments SA, is a diversified company that invests in healthcare, hospitality, telemedicine, life sciences and lifestyle. It owns and operates outpatient surgical centres, hospitals, medical network, and center for prevention of aging, radiology, and dental medicine. Aevis Victoria owns and manages various five star hotels in Switzerland. It also provides lease facility to various hospitals under Swiss Medical Network and support over the long term. The company’s hospitals specialize in the therapeutic areas of orthopaedics, urology, gynaecology, general surgery, and obstetrics. It caters to pharmaceuticals and healthcare, real estate, medical tourism, and travel and tourism sectors. Aevis Victoria is headquartered in Fribourg, Switzerland.

Aevis Victoria SA (AEVS) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Aevis Victoria SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Aevis Victoria SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Aevis Victoria SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Aevis Victoria SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Aevis Victoria SA, Medical Devices Deals, 2012 to YTD 2018 9
Aevis Victoria SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Aevis Victoria SA, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Genolier Swiss Medical Network To Acquire Hopital de la Providence 11
Debt Offering 12
Aevis Victoria Raises USD55.69 Million in Public Offering of 2.25% Senior Notes Due 2020 12
Acquisition 13
Mediclinic International to Acquire 98% Interest in Swissana Clinic for USD12.4 Million 13
Genolier Swiss Medical Network To Acquire Schmerzklinik Basel 14
Genolier Swiss Medical Network Completes Acquisition Of Klinik Villa Im Park 15
Genolier Swiss Medical Completes Acquisition Of 20% Stake In Klinik Pyramide 16
Genolier Swiss Medical Completes Acquisition Of Gruppo Ospedaliere Ars Medica 17
Genolier Swiss Medical Network Completes Acquisition Of Privatklinik Obach 18
Aevis Victoria SA – Key Competitors 19
Aevis Victoria SA – Key Employees 20
Aevis Victoria SA – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 23
Financial Announcements 23
Mar 29, 2018: Aevis Victoria: Publication Of Annual Report 2017 23
Nov 17, 2017: AEVIS VICTORIA: Total revenues at 30 September 2017 increased by 15.4% to CHF 487.0 million 24
Jun 06, 2017: AEVIS VICTORIA: Q1 2017 total revenue increased by 17.0% to CHF 169.7 million 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Aevis Victoria SA, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Aevis Victoria SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Aevis Victoria SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Aevis Victoria SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Aevis Victoria SA, Deals By Therapy Area, 2012 to YTD 2018 8
Aevis Victoria SA, Medical Devices Deals, 2012 to YTD 2018 9
Aevis Victoria SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Genolier Swiss Medical Network To Acquire Hopital de la Providence 11
Aevis Victoria Raises USD55.69 Million in Public Offering of 2.25% Senior Notes Due 2020 12
Mediclinic International to Acquire 98% Interest in Swissana Clinic for USD12.4 Million 13
Genolier Swiss Medical Network To Acquire Schmerzklinik Basel 14
Genolier Swiss Medical Network Completes Acquisition Of Klinik Villa Im Park 15
Genolier Swiss Medical Completes Acquisition Of 20% Stake In Klinik Pyramide 16
Genolier Swiss Medical Completes Acquisition Of Gruppo Ospedaliere Ars Medica 17
Genolier Swiss Medical Network Completes Acquisition Of Privatklinik Obach 18
Aevis Victoria SA, Key Competitors 19
Aevis Victoria SA, Key Employees 20
Aevis Victoria SA, Subsidiaries 21

List of Figures
Aevis Victoria SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Aevis Victoria SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Aevis Victoria SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Aevis Victoria SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Aevis Victoria SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Aevis Victoria SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Aevis Victoria SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Aevis Victoria SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Aevis Victoria SA, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Aevis Victoria SA (AEVS):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Otello Corp ASA (OTELLO):企業の財務・戦略的SWOT分析
    Otello Corp ASA (OTELLO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • UbiQ Bio BV:製薬・医療:M&Aディール及び事業提携情報
    Summary UbiQ Bio BV (UbiQ) is a biotechnology company that develops and commercializes ubiquitinated peptides and assays that enables drug discovery in Ubiquitin field. The company provides products such as ubiquitin-proteasome system, high throughput screening assay reagents and ubiquitinated polyp …
  • Vitamin Shoppe Inc (VSI):企業の財務・戦略的SWOT分析
    Vitamin Shoppe Inc (VSI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Adept Technology, Inc.:企業の戦略的SWOT分析
    Adept Technology, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Murphy Oil Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Murphy Oil Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Murphy Oil Corp (Murphy) is an international independent oil and gas exploration and production company. It explores for and produces crude oil, natural gas, and natural gas liquids. The company oper …
  • Meritor, Inc. (MTOR):企業の財務・戦略的SWOT分析
    Meritor, Inc. (MTOR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Gulf Cement Company PSC:企業の戦略・SWOT・財務情報
    Gulf Cement Company PSC - Strategy, SWOT and Corporate Finance Report Summary Gulf Cement Company PSC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • OncoSil Medical Ltd (OSL)-医療機器分野:企業M&A・提携分析
    Summary OncoSil Medical Ltd (OncoSil), formerly NeuroDiscovery Ltd is a medical device company that develops and commercializes treatments for patients with pancreatic and liver cancer. The company’s lead product include oncosil, a brachytherapy device that emits beta radiation and is implanted dire …
  • Staatsolie Maatschappij Suriname NV:企業の戦略的SWOT分析
    Staatsolie Maatschappij Suriname NV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Infinite Group Inc (IMCI):企業の財務・戦略的SWOT分析
    Summary Infinite Group Inc (IGI) is a technology company that offers IT service and support solutions virtualization and cybersecurity. The company offers Nodeware, an automated network vulnerability management system that assesses vulnerabilities in a computer network using scanning technology. Its …
  • Spectris plc:企業の戦略・SWOT・財務情報
    Spectris plc - Strategy, SWOT and Corporate Finance Report Summary Spectris plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Accugenomics Inc:企業の製品パイプライン分析
    Summary Accugenomics Inc (Accugenomics) is a developer of oncology molecular diagnostics. The company develops and markets gene expression tests to diagnose and monitor cancer treatment. It offers gene expression tests including lung cancer risk test, standardized BCR-ABL molecular diagnostics test …
  • Malakoff Corporation Berhad:発電所・企業SWOT分析
    Malakoff Corporation Berhad - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key e …
  • Medigus Ltd (MDGS):企業の財務・戦略的SWOT分析
    Summary Medigus Ltd (Medigus) is a medical device company that develops, produces and markets endoscopic surgical devices for minimally invasive medical procedures. The company flagship product, Medigus ultrasonic surgical endostapler (MUSE) system, a comprehensive endoscopic device for the treatmen …
  • Adimmune Corp (4142):製薬・医療:M&Aディール及び事業提携情報
    Summary Adimmune Corp (Adimmune) is a biopharmaceutical company that manufactures diagnostics, vaccines, and biological products for various diseases. The corporation’s products include tetanus toxoid adsorbed vaccine, influenza vaccine, Japan encephalitis vaccine, and ah1n1 vaccine. It also provide …
  • Thai Airways International Public Co Ltd:企業の戦略・SWOT・財務分析
    Thai Airways International Public Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Thai Airways International Public Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Raiffeisen Bank International AG:企業の戦略・SWOT・財務情報
    Raiffeisen Bank International AG - Strategy, SWOT and Corporate Finance Report Summary Raiffeisen Bank International AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Canon Medical Systems Corp:企業の戦略的SWOT分析
    Canon Medical Systems Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Aeroports de Paris SA:戦略・SWOT・企業財務分析
    Aeroports de Paris SA - Strategy, SWOT and Corporate Finance Report Summary Aeroports de Paris SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Eurofins Scientific SE:企業の戦略・SWOT・財務分析
    Eurofins Scientific SE - Strategy, SWOT and Corporate Finance Report Summary Eurofins Scientific SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆